Skip to search formSkip to main contentSkip to account menu

Budesonide / formoterol

Known as: BUDESONIDE/FORMOTEROL, formoterol and budesonide 
National Institutes of Health

Related topics

Related topics

2 relations
Budesonideformoterol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials
BackgroundIn many patients with mild asthma, the low frequency of symptoms and the episodic nature of exacerbations make… 
Review
2013
Review
2013
Fluticasone Propionate/Formoterol Fumarate: A Review of Its Use in Persistent Asthma
The corticosteroid fluticasone propionate (fluticasone) and the long-acting β2-adrenoceptor agonist formoterol fumarate… 
2010
2010
Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
Asthma guidelines recommend titrating maintenance medications to the lowest effective dose. This study assessed the efficacy and… 
2010
2010
The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children.
Few studies have evaluated inhaled corticosteroid (ICS)/long-acting beta(2)-adrenergic agonist combination therapy in asthmatic… 
2008
2008
Budesonide/formoterol in the treatment of asthma
Budesonide/formoterol is a combination of an inhaled corticosteroid plus a long-acting β2-agonist available as a dry-powder… 
2008
2008
Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction.
Allergic asthma is characterized by airway inflammation in response to chronic allergen exposure, resulting in remodeling of the… 
Review
2007
Review
2007
Acute asthma intervention: insights from the STAY study.
2005
2005
Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting β2‐agonists: addition of montelukast in an open-label pilot study
ABSTRACT Background: Airway inflammation and symptoms often persist in asthma patients despite treatment with inhaled… 
Review
2004
Review
2004
Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing.
2004
2004
The effect of adjustable dosing with budesonide/formoterol on health-related quality of life and asthma control compared with fixed dosing
SUMMARY Background: Budesonide/formoterol in a single inhaler is an effective therapy for asthma. We investigated whether… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)